Apolipoprotein E genotype, coagulation, and survival following acute stroke.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 11571342.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors hypothesized that divergent influences of the APOE epsilon4 allele on ischemic and hemorrhagic stroke survival might result from differences in coagulation profiles. In 49 hemorrhagic stroke patients, epsilon4 carriers had higher partial thromboplastin time ratios (p < 0.01) than non-epsilon4 carriers. Among 529 ischemic stroke patients, increasing epsilon4 allele dose was associated with improved survival (p = 0.03) after adjusting for baseline NIH stroke scale (p = 0.00001) and partial thromboplastin time ratio (p = 0.01). Relative anticoagulation does not fully explain the survival advantage in epsilon4-carrying ischemic stroke patients.
Medical subject headings
- Apolipoproteins E
- Cerebral Hemorrhage
- Cerebral Infarction
- Genotype
- International Normalized Ratio
- Partial Thromboplastin Time